Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Aug;30(2):323–324. doi: 10.1128/aac.30.2.323

Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.

J Chan, B J Luft
PMCID: PMC180543  PMID: 3767344

Abstract

Roxithromycin (RU 28965), an ether oxime derivative of erythromycin, protected mice against a lethal infection with the virulent RH strain of Toxoplasma gondii. Therapy begun 24 h before, 2 h after, and 24 h after infection with 2 X 10(3) tachyzoites protected 90, 80, and 50% of the mice, compared with 0% of untreated controls (P less than 0.05 to 0.001). Toxoplasma was isolated in less than 20% of surviving roxithromycin-treated mice.

Full text

PDF
323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlam T., Neu H. C. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984 Apr;25(4):529–531. doi: 10.1128/aac.25.4.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Jones R. N., Barry A. L., Thornsberry C. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrob Agents Chemother. 1983 Aug;24(2):209–215. doi: 10.1128/aac.24.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. KAUFMAN H. E., CALDWELL L. A. Pharmacological studies of pyrimethamine (daraprim) in man. AMA Arch Ophthalmol. 1959 Jun;61(6):885–890. doi: 10.1001/archopht.1959.00940090887003. [DOI] [PubMed] [Google Scholar]
  4. KAUFMAN H. E., GEISLER P. H. The hematologic toxicity of pyrimethamine (daraprim) in man. Arch Ophthalmol. 1960 Jul;64:140–146. doi: 10.1001/archopht.1960.01840010142016. [DOI] [PubMed] [Google Scholar]
  5. KUTSCHER A. H., LANE S. L., SEGALL R. The clinical toxicity of antibiotics and sulfonamides; a comparative review of the literature based on 104, 672 cases treated systemically. J Allergy. 1954 Mar;25(2):135–150. doi: 10.1016/0021-8707(54)90153-7. [DOI] [PubMed] [Google Scholar]
  6. Luft B. J., Remington J. S. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii. J Immunol. 1984 May;132(5):2375–2380. [PubMed] [Google Scholar]
  7. Remington J. S. Trimethoprim-sulfamethoxazole in murine toxoplasmosis. Antimicrob Agents Chemother. 1976 Feb;9(2):222–223. doi: 10.1128/aac.9.2.222. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES